Trial Profile
Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients: A Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Etelcalcetide (Primary) ; Alfacalcidol
- Indications Secondary hyperparathyroidism
- Focus Pharmacodynamics
- Acronyms EtECAR-HD
- 29 Feb 2020 Status changed from recruiting to completed.
- 24 Oct 2019 Trial design for EtECAR-HD published in the Trials
- 24 Jul 2019 Status changed from active, no longer recruiting to recruiting.